Fingerprint
Dive into the research topics of 'Does the Poly (ADP-Ribose) Polymerase Inhibitor Veliparib Merit Further Study for Cancer-Associated Weight Loss? Observations and Conclusions from Sixty Prospectively Treated Patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically